HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunohistochemical and ultrastructural investigation on cutaneous neuroendocrine carcinoma: report of a case and review of the literature.

Abstract
We report a tumor in an 80-year-old man that was difficult to distinguish from other tumors, i.e., small cell carcinoma of the lung, PNET/Ewing tumor, malignant lymphoma, or malignant melanoma (amelanotic), and which was finally identified as cutaneous neuroendocrine carcinoma using immunohistochemical and ultrastructural methods. Autopsy did not show any tumors in the lungs, excluding the possibility of small cell carcinoma of the lung. Immunohistochemistry tests gave negative results for LCA, UCHL-1, CD3, and CD20, thereby excluding malignant lymphoma, and the negative results for S-100 protein and HMB-45 ruled out malignant melanoma. The possibility of PNET/Ewing sarcoma was also excluded because of negativity for CD99. In addition, the ultramicrostructure showed intercellular junctional complexes and neuroendocrine granules, indicating that the tumor had characteristics of both epithelial and neuroendocrine tissues. We therefore diagnosed the primary carcinoma of the skin as cutaneous neuroendocrine carcinoma.
AuthorsHideaki Ishii, Takashi Joshita, Nagahisa Matsuyama, Takashi Uchida, Akio Ishikawa, Yoshiro Ebihara
JournalMedical molecular morphology (Med Mol Morphol) Vol. 39 Issue 3 Pg. 164-8 (Sep 2006) ISSN: 1860-1480 [Print] Japan
PMID16998628 (Publication Type: Case Reports, Journal Article)
Topics
  • Aged, 80 and over
  • Carcinoma, Neuroendocrine (diagnosis, ultrastructure)
  • Diagnosis, Differential
  • Fatal Outcome
  • Humans
  • Immunohistochemistry
  • Male
  • Skin Neoplasms (diagnosis, ultrastructure)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: